Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda - Kitonsa, Jonathan; Nsubuga, Rebecca; Mayanja, Yunia; Kiwanuka, Julius; Nikweri, Yofesi; Onyango, Martin; Anywaine, Zacchaeus; Ggayi, Abu-Baker; Kibengo, Freddie Mukasa; Kaleebu, Pontiano; Day, Jeremy (PLoS neglected tropical diseases, 2020)
Keywords: Adult; AIDS-Related Opportunistic Infections - drug therapy; AIDS-Related Opportunistic Infections - mortality; Amphotericin B; Amphotericin B - therapeutic use; Anti-Inflammatory Agents - therapeutic use; Antifungal agents; Antifungal Agents - therapeutic use; Antigens; Antiretroviral drugs; Antiretroviral therapy; Biology and Life Sciences; Blindness; Blood; Blood cells; Body Weight; Cell culture; Cerebrospinal fluid; Cohort Studies; Coma; Convulsions; Data collection; Demographic variables; Dexamethasone; Dexamethasone - therapeutic use; Ears; Eye (anatomy); Female; Fever; Fluconazole; Fluconazole - therapeutic use; Fungal infections; Fungi; Fungicides; Gender; Health services; Hearing; Hearing loss; HIV; Hospitals; Human immunodeficiency virus; Humans; Hygiene; Intravenous administration; Leukocytes; Male; Medical research; Medical sciences; Medicine; Medicine and Health Sciences; Meningitis; Meningitis, Cryptococcal - drug therapy; Meningitis, Cryptococcal - mortality; Mortality; Patients; Placebos; Questionnaires; Randomization; Research facilities; Retrospective Studies; Risk Factors; Seizures; Steroids; Stiffness; Therapy; Tropical climate; Tropical diseases; Uganda; Variables; Viruses; White blood cells; Yeast; Yeasts; Uganda; Africa